The aims of this study were i) to evaluate sLRP1 and ANP levels in newly diagnosed T2DM patients as compared to healthy controls, and ii) to determine the effect of achieving metabolic optimization on these circulating biomarkers. This evidence concerns the gene NPPA and type 2 diabetes mellitus.